Nasal obstruction is a common complaint prompting presentation to an otolaryngologist. Many studies have been performed quantifying and describing the impact of a number of factors on symptoms of nasal obstruction, including anatomical, neoplastic, infectious, and inflammatory causes. Despite this scrutiny, no attention has been paid to the nasal vibrissae as a potential anatomical contributor to nasal obstruction. The proposed study intends to elucidate that contribution, if any exists.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
60
Patients will have oxymetazoline administered prior to assessment of outcome measures to ensure minimal impact of erectile mucosal tissue on measurement.
Afrin will be administered to minimize the impact of erectile mucosal tissue on obstruction.
Mayo Clinic in Rochester
Rochester, Minnesota, United States
Nasal airflow/pressure
Objective measures include airflow and pressure as assessed by Rhinomanometry.
Time frame: Participants will undergo assessment over a 30 minute period, no follow-up
Subjective Nasal Obstruction
Subjective measures will be assessed via the modified version of the NOSE outcome instrument-a validated test of subjective nasal obstruction
Time frame: Participants will undergo assessment over a 30 minute period, no follow-up
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.